Ellodi Pharmaceuticals

Ewing Township, United States Founded: 2020 • Age: 6 yrs
Therapeutics for Eosinophilic Esophagitis are developed by Ellodi Pharmaceuticals.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Ellodi Pharmaceuticals

Ellodi Pharmaceuticals is a company based in Ewing Township (United States) founded in 2020. Ellodi Pharmaceuticals offers products and services including APT-1011 and FLUTE 3 Study. Ellodi Pharmaceuticals operates in a competitive market with competitors including Phathom Pharmaceuticals, VectivBio, Guangzhou Zhiyi Pharmaceutics, Lumena Pharma and Kamui Pharma, among others.

  • Headquarter Ewing Township, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ellodi Pharmaceuticals

Ellodi Pharmaceuticals offers a comprehensive portfolio of products and services, including APT-1011 and FLUTE 3 Study.

Product name locked
Category locked
Primary

Novel treatment for Eosinophilic Esophagitis through clinical development

Product name locked
Category locked
Locked

Research study evaluating therapies for Eosinophilic Esophagitis patients

Funding Insights of Ellodi Pharmaceuticals

Premium access

Detailed funding history for Ellodi Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ellodi Pharmaceuticals

Investments
Premium access

Investment portfolio details for Ellodi Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ellodi Pharmaceuticals

Premium access

Detailed financials for Ellodi Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ellodi Pharmaceuticals Comparisons

Ellodi Pharmaceuticals Primary company
Description
Therapeutics for Eosinophilic Esophagitis are developed by E...
Location
Ewing Township, United States
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ellodi Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ellodi Pharmaceuticals

Ellodi Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phathom Pharmaceuticals, VectivBio, Guangzhou Zhiyi Pharmaceutics, Lumena Pharma and Kamui Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals.
Locked Locked Locked
Transformative therapeutics for rare diseases are developed.
Locked Locked Locked
Second-generation probiotics are developed for gastrointestinal disorders.
Locked Locked Locked
Passionately pursuing better treatments for adults and children with rare liver diseases.
Locked Locked Locked
Probiotic medicines for treating gastrointestinal diseases are developed.
Premium access

Detailed competitors of Ellodi Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ellodi Pharmaceuticals

Premium access

Complete news archive for Ellodi Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ellodi Pharmaceuticals

Ellodi Pharmaceuticals was founded in 2020.

Ellodi Pharmaceuticals is headquartered in Ewing Township, United States. It is registered at Ewing Township, New Jersey, United States.

Ellodi Pharmaceuticals was founded in 2020 and is based in Ewing Township, United States. Focus is placed on the pharmaceutical sector, specifically gastroenterology, where therapeutics for disorders like Eosinophilic Esophagitis are developed. Proprietary orally disintegrating tablets, including APT-1011 and Esomeprazole ODT, are offered to address gastrointestinal conditions and rare chronic allergic inflammatory diseases. Operations center on research and product innovation for these targeted health issues.

Ellodi Pharmaceuticals's top competitors include Phathom Pharmaceuticals, VectivBio and Lumena Pharma.

Ellodi Pharmaceuticals offers APT-1011 and FLUTE 3 Study.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available